A new locus is described that determines an alloantigen on the surface of lymphocytes. It differs from loci previously described in that the corresponding antibody, at least in most antisera, reacts almost exclusively with node lymphocytes, and weakly or not at all with thymus lymphocytes. Positive strains include C57BL/ 6, C57BL/1O, C57L, C57BR/cd, and RF; negative strains include BALB/c, C3H, and SJL. The symbol Ly-4 is assigned, with the C57BL/6 allele being Ly-4b, and the BALB/c allele Ly-4a.
A dozen loci are known in mice that determine alloantigens on the surface of red cells or lymphocytes (for reviews, see refs. 1 and 2). Seven red cell alloantigen loci have been described, designated Ea-1 to Ea-7 (3-10). The TIa locus (11) determines an alloantigen confined to thymus lymphocytes. The antigen of another locus, Thy-i or 0 (12) , is a useful marker for thymusderived or T lymphocytes; unlike the antigen determined by Tla, it persists after the lymphocytes leave the thymus. The antigens of Ly-1 (13, 14) and Ly-2 (13) occur on node and spleen, as well as thymus, lymphocytes but, like the Tla and Thy-i antigens, are most easily studied with lymphocytes from the thymus. An alloantigen of plasma cells is determined by the Pca locus (15) . The major histocompatibility locus (or complex) of the mouse, H-2, not only is important in graft rejection, but is also both a blood group and a lymphocyte group locus (16) , therein holding a unique position among histocompatibility loci.
The numerous inbred and congenic (17) mouse strains, typed for the known alleles of the various cell-surface alloantigen-determining loci (2) , make it possible to set up recipient-donor combinations for the production of antisera that should yield specific, known antibodies, or antibodies that can be identified at once as unknown. Tested against lymphocytes by the dye exclusion (18) or chromium label (19) cytotoxic methods, the unknown antibodies might be expected to expand an interesting new group of loci. Because tests with antisera in which non-H-2 antibodies were not excluded suggested that unknown non-H-2 antibodies may be common, we decided to institute a planned search for such antibodies. We have found that antibodies are produced by the majority of recipient-donor combinations selected to exclude known reagents. Most of the antibodies are weak, some too weak to work with. Analysis is sometimes complicated by the number of antibodies present, and by a tendency to low maximum lysis (suggestive of reaction with a restricted category of lymphocytes), but several workable antisera have been obtained. We report here antisera which identify a new lymphocyte alloantigen locus. The locus is distinct from non-H-2 loci heretofore described in that its antigen is more readily demonstrated on node than on thymus lymphocytes.
METHODS
Mice. Mice came from the personal colonies of Snell or Bailey or from the Production Department of The Jackson Laboratory. For some strains, frequently referred to, we shall use the standard abbreviations. Thus: C57BL/6 = B6, C57BL/10 = BlO, BALB/c = C, DBA/2 = D2.
Antisera. Antisera were usually produced in hybrid recipients, since this procedure assists in the exclusion of unwanted antibodies. Donor cells for injection were prepared in the cytosieve (20) Stimpfling (16) . Genetic Methods. Two methods were used to test the identity or nonidentity with known loci of the locus under study.
The first was the typing of backcrosses. (We use backcross in the genetic sense, to mean the crossing of F1 hybrids to the multiple recessive.) Two backcrosses were used: (B6 x RF) x HTG and (B6 x C3H) x C3H. The second of these was continued into later backcross generations to introduce genes from B6 onto a C3H background. Relevant data were obtained from generations N2 through N5.
The second method made use of recombinant-inbred (RI) strains (33) . These are inbred strains produced by brothersister inbreeding after a cross between two established inbred strains. The alleles at every locus by which the parent strains differ become fixed in patterns which are characteristic of the individual loci. If a locus under test has a different pattern from a known locus, it of necessity is different. Identical patterns establish a presumption of identity, but may rarely be fortuitous. The more loci that are tested, the greater the chance of finding a significant match with any new locus. The RI lines thus function as a "frozen" recombinant generation, to which one can continually have recourse for new tests. The seven RI lines used came from an initial C x B6 cross (33) , and are designated CXBD, CXBE, CXBG, CXBH, CXBI, CXBJ, and CXBK.
RESULTS
Several antisera produced in recipient-donor combinations that could not yield antibodies against known lymphocyte surface alloantigens nevertheless contained lymphocytotoxic antibodies. Some of these were obviously complex, but served to suggest modifications of the recipient-donor combination that should, and sometimes did, yield more interpretable antisera. One antiljody has now been thoroughly characterized. It defines a new locus, which we call Ly-4.
Five of the antisera in which it occurred are shown in Table 1 . Of these, AS-586, (BALB/c x SWR) anti-B1O.D2, appeared to be the most nearly monospecific, and we have adopted it as the standard. A repeat antiserum showed essentially identical properties, though with the suggestion of a weak contaminant not present in the original. An anti-Ea4.2 was present in addition to the lymphocytotoxic antibody, but this additional antibody is reactive only with erythrocytes.
The cytotoxic activity of AS-586 was almost exclusively with node lymphocytes; reactions with thymus lymphocytes were negative or very weak, especially in the early bleedings. AS-605, (BALB/c x A.BY) anti-CXBJ, and AS-661, (DBA/2 x SWR) anti-B1O.D2, were very similar, but AS-605 was generally weak and AS-661 contained a weak, but unidentified, contaminant. AS-564, (DA x 129) anti-B10, reacted with thymus as well as node lymphocytes of the donor, and of at least some other positive strains. It also gave a low-titered reaction with strain CXBH not shown by AS-586, and hence is probably indicative of a contaminant antibody. AS-569, (A x CE) anti-C57BR/cd, contained a second, strong node cytotoxic antibody which we have partly characterized.
The pattern of strain reactivity, as inferred primarily from results with AS-586 and its repeat, but also in part from results with the other antisera, is as follows: Positive for Ly-4: C57BL/6By, C57BL/lOSn, C57L/J, C57BR/cdJ, C58/J, LG/J, LG/Ckc, MA/J, PRO/Re, RF/J, WB/Re, WC/Re, WK/Re. Negative for Ly-4: A/WySn, AKR/J, BALB/cJ, C3H/HeDiSn, DA/HuSn, DBA/1J, DBA/2J, HTG/GoSfSn, LT/Sv, P/J, PL/J, SEA/GnJ, SJL/J, SWR/J, 129/J, Sublines other than those indicated gave, in so far as tested, similar results.
Titers with positive node lymphocytes were usually of the order of 1/40, with a good maximum lysis. Positive strains C57BR/cdJ, C58/J, MA/J, and RF/J consistently gave a considerably lower maximum lysis, and often a lower titer. These are all H-2k strains, suggesting that there may be an interaction between H-e and Ly-4. This suggestion has been checked in two ways. The (B6 x C3H) x C3H backcross The strains distribution pattern of positive reactions with AS-586 and related antisera and the tendency of these antisera to react exclusively or predominantly with node lymphocytes suggests that they identify a new locus. More positive evidence comes from the backcross tests. The results are given in Tables 2 and 3 . Positive reactions with AS-586 segregated independently from JI-2, Ea-2, Ea-4, Ea-7, Ly-i, Ly-2, and Thy-i. Since Ly-3 (34) shows completed linkage with Ly-2 (it may be an allele), and Tla shows very close linkage with H-2, tests with these were regarded as unnecessary. Tests were not run against all Ea (erythrocyte antigen) loci, but the marked serological differences make identity unlikely. The same conclusion applies to Pca, the plasma-cell-antigen locus (15) .
Additional evidence on independence comes from results with the CXB recombinant inbred lines (Table 4) Because, for several non-H-2 alloantigens, the specificity of the widely used C57BL strain and its various sublines has been assigned the number 2, we suggest calling the Ly-4 specificity of C57B3L Ly-4.2, and the corresponding allele Ly-4b. Since C57BL is a reacting strain, and we have not as yet identified the reciprocal antibody, this choice assigns the 1 specificity and the a allele to the nonreactors. A distinctive feature of some of the anti-Ly-4 sera is that they react in the cytotoxic test exclusively-or almost exclusively-with node, and not with thymus, lymphocytes. There is some evidence that the antisera which show thymic reactions contain additional antibodies, but we cannot exclude the possibility that some variants of anti-Ly-4 are thymus reactive. In any case the antigen is probably oii the thymus, since we produce our antisera with priming injections of thymus cells only. One of the known differences between node and thymus lymphocytes which might account for differences in reactivity with different antibodies is that the former include a considerable proportion of bone-marrowderived or B lymphocytes. One antigenic difference between 13 and T (thymus-derived) lymphocytes is already well established-the T lymphocytes possess and the B lymphocytes lack the Thy-1 or 0 antigen (35 
